McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference

McKesson Corporation (NYSE: MCK) will present at the 42^nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT (12:45 PM ET). Executive leadership will provide a company overview followed by a fireside chat.

The audio webcast will be available live at McKesson’s Investor Relations website at investor.mckesson.com, along with the company’s slide presentation.

McKesson’s Board of Directors Elects Kevin Ozan as New Director

The McKesson board of directors has elected Kevin Ozan as director and member of the Audit Committee and Finance Committee, effective January 8, 2024. With the election of Ozan, McKesson’s board of directors increases from 11 to 12 members, 11 of whom are independent.

“We’re pleased to welcome Kevin to the McKesson Board,” said Donald Knauss, McKesson’s independent board chair. “His extensive executive leadership background in strategy and finance will be instrumental as the company continues to deliver on its growth initiatives, advancing health outcomes for all.”

Ozan recently retired from his role as senior executive vice president of strategic initiatives at McDonald’s Corporation. During his 25-year tenure with the global food service retailer, Ozan also served as executive vice president and chief financial officer and held multiple leadership roles overseeing financial and investor relations teams. Prior to McDonald’s, he worked for over a decade in Ernst & Young’s audit and mergers and acquisitions practices.

In addition to McKesson, Ozan currently serves on the board of Cineworld, a private company with one of the largest global cinema businesses. Ozan holds a bachelor’s degree in accounting from the University of Michigan and a master’s degree in business from the Kellogg School of Management at Northwestern University.

McKesson Acquires Compile

On January 4, 2024, McKesson acquired Compile, a healthcare data platform that aggregates and integrates data from across the US healthcare system to characterize providers and their patient panels. The acquisition is anticipated to provide a centralized commercial data platform for McKesson and accelerate its capabilities in commercializing data and providing insights to biopharma customers.

About McKesson Corporation

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.